Compass Therapeutics Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Compass Therapeutics Inc.
Former names: Olivia Ventures, Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation: Delaware
Headquarters city: Boston
Headquarters state / province: Massachusetts
Headquarters country: United States
Fiscal year end: December
Ticker symbol: CMPX
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001738021

Board of directors

Follow this board

Carl L. Gordon · Director Overboarded
Since 2023
David M. Wurzer · Director
Since 2023
Ellen Chiniara · Director
Since 2023
James P. Boylan · Director
Since 2024
Mary Ann Gray · Director
Since 2023
Philip Ferneau · Director
Since 2023
Richard S. Lindahl · Director
Since 2023
Thomas J. Schuetz · Director · CHIEF EXECUTIVE OFFICER
Since 2023
Vered Bisker-Leib · Director · CHIEF EXECUTIVE OFFICER
Since 2024

Chief executives

Thomas J. Schuetz · CHIEF EXECUTIVE OFFICER

Dates unknown

Vered Bisker-Leib · CHIEF EXECUTIVE OFFICER

Dates unknown

Director election results

Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Thomas J. Schuetz

84.5%
Richard S. Lindahl

84.9%

Board connections

3 of this board's directors also sit on 12 other boards. 12 are in the same sector.

Shared director Other board Same sector

Keros Therapeutics Inc. Same sector
via Carl L. Gordon and Mary Ann Gray
ADARx Pharmaceuticals Inc. Same sector
via Carl L. Gordon
Adicet Bio Inc. Same sector
via Carl L. Gordon
ArriVent BioPharma Inc. Same sector
via Carl L. Gordon
BlossomHill Therapeutics Inc. Same sector
via Carl L. Gordon
CAMP4 Therapeutics Corporation Same sector
via James P. Boylan
Electra Therapeutics Inc. Same sector
via Carl L. Gordon
Immunome Inc. Same sector
via James P. Boylan
MBX Biosciences Inc. Same sector
via Carl L. Gordon
Palisade Bio Inc. Same sector
via Mary Ann Gray
Scribe Therapeutics Inc. Same sector
via Carl L. Gordon
Zenas BioPharma Inc. Same sector
via James P. Boylan

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $21,250; 2 purchases by 1 insider
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Oct 1, 2026	Lerner Neil Officer (Chief Accounting Officer)	Open-market purchase	+20,000	$0.92	$18,400
Sep 24, 2026	Lerner Neil Officer (Chief Accounting Officer)	Open-market purchase	+2,500	$1.14	$2,850
Apr 29, 2026	Anderman Jonathan Officer (General Counsel)	Grant or award	+25,000	$1.89	$47,250
Apr 29, 2026	Lerner Neil Officer (Chief Accounting Officer)	Grant or award	+15,000	$1.89	$28,350
Feb 8, 2026	Thomas J. Schuetz Director, Officer (CHIEF EXECUTIVE OFFICER)	Shares withheld for tax	−36,687	$6.52	$239,199
Jan 9, 2026	Thomas J. Schuetz Director, Officer (CHIEF EXECUTIVE OFFICER)	Shares withheld for tax	−46,777	$5.35	$250,257
Jan 2, 2026	Shin Barry Officer (CFO)	Grant or award	+125,000	$5.17	$646,250
Jan 2, 2026	Thomas J. Schuetz Director, Officer (CEO)	Grant or award	+250,000	$5.17	$1,292,500
Jan 2, 2026	Lerner Neil Officer (Chief Accounting Officer)	Grant or award	+62,500	$5.17	$323,125
Jan 2, 2026	Anderman Jonathan Officer (General Counsel)	Grant or award	+150,000	$5.17	$775,500
Nov 16, 2025	Thomas J. Schuetz Director, Officer (CHIEF EXECUTIVE OFFICER)	Shares withheld for tax	−44,025	$4.83	$212,641
May 27, 2025	Thomas J. Schuetz Director, Officer (CHIEF EXECUTIVE OFFICER)	Open-market purchase	+10,000	$2.11	$21,100
Apr 9, 2025	Carl L. Gordon Director, 10% owner	Open-market sale	−3,571,428	$1.59	$5,678,571
Apr 9, 2025	OrbiMed Capital GP VI LLC Director, 10% owner	Open-market sale	−3,571,428	$1.59	$5,678,571
Apr 7, 2025	Anderman Jonathan Officer (Gen Counsel & Corporate Sec)	Open-market purchase	+20,000	$1.54	$30,800

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Compass Therapeutics Inc.

Who is the CEO of Compass Therapeutics Inc.?

Thomas J. Schuetz is Compass Therapeutics Inc.'s CHIEF EXECUTIVE OFFICER.

How many directors are on Compass Therapeutics Inc.'s board?

Compass Therapeutics Inc.'s board has 9 directors: Carl L. Gordon, David M. Wurzer, Ellen Chiniara, James P. Boylan, Mary Ann Gray, Philip Ferneau, Richard S. Lindahl, Thomas J. Schuetz and Vered Bisker-Leib.

Are Compass Therapeutics Inc. insiders buying or selling shares?

Over the last 12 months, Compass Therapeutics Inc. insiders bought $21,250 of shares in 2 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Compass Therapeutics Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="compass-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.